Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
Randomized Phase III Study of Preoperative Chemotherapy Followed by Surgery Versus Surgery Alone in Locally Advanced Gastric Cancer (cT3 and cT4NxM0)
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Terminated
low accrual
Other terminated trials from European Organisation for Research and Treatment of Cancer - EORTC
- Medulloblastoma · Phase PHASE2 · Sep 2025
- Malignant Pleural Mesothelioma · Phase PHASE2 · Jan 2024
- Advanced Soft-tissue Sarcoma · Phase PHASE3 · Nov 2023
- Breast Cancer · Oct 2023
- Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) · Phase PHASE2 · Apr 2023
See all terminations from European Organisation for Research and Treatment of Cancer - EORTC
A PHASE3 clinical study on Gastric Cancer, this trial is terminated or withdrawn. The trial is conducted by European Organisation for Research and Treatment of Cancer - EORTC and has accumulated 6 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Jul 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Organisation for Research and Treatment of Cancer - EORTC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Berlin, Germany , Brussels, Belgium , Cairo, Egypt , Cologne, Germany , Dresden, Germany , Düsseldorf, Germany , Erlangen, Germany , Essen, Germany , Frankfurt, Germany , Homburg, Germany and 6 more locations